CRISPR Therapeutics (CRSP) Stock on 7 December 2025: Latest Price, News, Forecasts and Gene‑Editing Outlook

CRISPR Therapeutics (CRSP) Stock on 7 December 2025: Latest Price, News, Forecasts and Gene‑Editing Outlook

CRISPR Therapeutics AG (NASDAQ: CRSP) is finishing 2025 in classic high‑beta biotech fashion: big science, big headlines, and big disagreement about where the stock goes next. As of the last U.S. trading session on Friday, 5 December 2025, CRSP changed hands at about $56.88 per share, implying a market value just under $5.9 billion. The stock sits well above its 52‑week low near $30 but below its high around $78, underlining just how wild the ride has been for gene‑editing investors.MarketBeat Below is a rundown of the latest news, institutional moves, analyst forecasts and technical signals as of 7 December
7 December 2025
US Stock Market Outlook for Monday, December 8, 2025: Fed Cut Countdown, Tariff Drama and Key Earnings to Watch

US Stock Market Outlook for Monday, December 8, 2025: Fed Cut Countdown, Tariff Drama and Key Earnings to Watch

Wall Street heads into Monday, December 8, 2025 with the major U.S. indexes hovering near record highs, investors bracing for a highly contentious Federal Reserve meeting, and a fresh burst of political risk from President Trump’s tariff fight at the Supreme Court. At the same time, Monday’s U.S. economic calendar is relatively quiet, making the session largely about positioning for the rest of the week. Here’s what you need to know before the U.S. stock market opens on Monday. 1. Where Wall Street Stands After Friday’s Close U.S. stocks finished Friday, December 5, modestly higher after a softer‑than‑expected inflation reading
Indian Stock Market Preview for Monday, December 8, 2025: Nifty, Sensex, RBI Cut, Rupee at 90 and Big F&O Rule Change

Indian Stock Market Preview for Monday, December 8, 2025: Nifty, Sensex, RBI Cut, Rupee at 90 and Big F&O Rule Change

India’s stock market heads into Monday’s session at an interesting crossroads: benchmark indices are at record highs, the rupee has just broken 90 per dollar, the RBI has delivered a surprise rate cut, and derivatives trading is about to change structurally with a new F&O pre‑open session kicking in from December 8. On top of that, it’s a packed IPO week and a crucial US Federal Reserve meeting is just days away. Here’s a comprehensive look at what you need to know before markets open on Monday, 8 December 2025. Note: This article is for information and education only, not
7 December 2025
UK Stock Market Outlook: What to Know Before the FTSE 100 Opens on Monday 8 December 2025

UK Stock Market Outlook: What to Know Before the FTSE 100 Opens on Monday 8 December 2025

The UK stock market heads into Monday’s open with the FTSE 100 sitting just below the 9,700 mark, energy and bank stocks under pressure, and a brand‑new consumer giant — The Magnum Ice Cream Company — about to start trading in London. Add in a looming US Federal Reserve rate decision, key UK GDP data later this week, and an ongoing reshuffle of FTSE constituents, and Monday’s session is set up to be busy even before the opening auction finishes. Here’s a detailed look at the main drivers UK investors should have on their radar before the London Stock Exchange
7 December 2025
Canada Stock Market Outlook: 7 Key Things to Know Before the TSX Opens Monday, December 8, 2025

Canada Stock Market Outlook: 7 Key Things to Know Before the TSX Opens Monday, December 8, 2025

After a choppy week that saw the S&P/TSX Composite brush fresh record highs before retreating, Canadian investors head into Monday’s open with a powerful mix of drivers: a blockbuster jobs report, a surging loonie, looming Bank of Canada and Federal Reserve decisions, and commodity prices hovering near multi‑year highs. Here’s what you need to know before markets open on Monday, December 8, 2025. 1. TSX Just Pulled Back From Record Highs Canada’s main stock index ended last week on a softer note, but still near all‑time highs: In other words, the TSX is still in an uptrend, but investors used
7 December 2025
Best AI Stocks to Buy Now (December 2025): 10 Ways to Invest in the Next Wave of the AI Boom

Best AI Stocks to Buy Now (December 2025): 10 Ways to Invest in the Next Wave of the AI Boom

Artificial intelligence is no longer just a theme trade. As of December 7, 2025, AI is reshaping entire supply chains—from GPUs and memory chips to power grids, cooling systems, and enterprise software. Recent headlines show both explosive growth and mounting constraints: chipmakers are sold out for years, electricity and cooling are becoming bottlenecks, and valuations are forcing investors to ask whether this is a boom… or a bubble. Reuters+2Reuters+2 At the same time, many analysts still see AI as a multi‑trillion‑dollar opportunity. Nvidia’s CEO has reiterated an estimate of $3–4 trillion in AI infrastructure spending by the end of the decade, while Advanced Micro Devices (AMD) is targeting $100
NEE Stock Today (December 7, 2025): NextEra Energy’s Latest News, Price Targets and Dividend Outlook

NEE Stock Today (December 7, 2025): NextEra Energy’s Latest News, Price Targets and Dividend Outlook

NextEra Energy (NYSE: NEE) has quietly become one of the most important stocks at the intersection of clean energy, artificial intelligence (AI) and dividend growth. As of the close on Friday, December 5, 2025, NEE traded around $83.13 per share, giving the company a market capitalization of roughly $173 billion. Shares now sit close to their 52‑week high of $87.53 after rebounding sharply from last year’s utility sell‑off, and they trade on a price‑to‑earnings ratio of about 26.4 and a forward P/E near 22.2, with a dividend yield of roughly 2.7%. StockAnalysis+1 Year to date, NEE has returned about 24%,
7 December 2025
Best Big Tech Stocks to Buy Now: 7 AI Giants Poised for 2026 Growth (December 7, 2025)

Best Big Tech Stocks to Buy Now: 7 AI Giants Poised for 2026 Growth (December 7, 2025)

Big Tech is still steering global markets as 2025 winds down, but the story has changed. The “Magnificent Seven” — Apple, Microsoft, Amazon, Alphabet, Meta, Nvidia and Tesla — just delivered another year of outsized earnings growth, yet their share prices have lagged in recent months as investors start asking tougher questions about AI, regulation, and valuations.Investopedia+1 At the same time, a historic build‑out in AI infrastructure is underway. Goldman Sachs estimates global AI‑related infrastructure spending could reach $3–4 trillion by 2030, and hyperscalers like Microsoft, Amazon, Meta and Alphabet are on track to spend roughly $350 billion in 2025 alone.Reuters Nvidia’s CEO
Salesforce (CRM) Stock Rebounds on AI Momentum: Is the ‘Dog of the Dow’ Now a 2026 Comeback Play?

Salesforce (CRM) Stock Rebounds on AI Momentum: Is the ‘Dog of the Dow’ Now a 2026 Comeback Play?

Salesforce (NYSE: CRM) has had a rough 2025, but the last few days have looked very different from most of the year. As of the latest close on Friday, December 5, 2025, Salesforce stock finished around $260.57, up about 5% on the day and roughly 13% over the past week, according to Stock Analysis and QuiverQuant data. StockAnalysis+1 Despite that short‑term rally, CRM remains one of the worst performers in the Dow Jones Industrial Average in 2025, with year‑to‑date losses somewhere between the low‑20% and nearly 30% depending on the data provider and measurement date. Barchart.com+1 The turning point: record
ENPH Stock Outlook: Enphase Energy’s EV Charger Push, Big-Money Buying and a Divided Wall Street Heading Into 2026

ENPH Stock Outlook: Enphase Energy’s EV Charger Push, Big-Money Buying and a Divided Wall Street Heading Into 2026

As of 7 December 2025, Enphase Energy’s stock (NASDAQ: ENPH) is trading around $31 per share, down more than 50% over the past year and still roughly 60% below its 52‑week high near $78.Ticker Nerd+1 Yet the company is simultaneously posting its best revenue in two years, rolling out new EV charging and battery software products, attracting major institutional investors — and drawing sharply mixed opinions from Wall Street. Below is a detailed look at the latest ENPH stock news, forecasts and analysis as of December 7, 2025, with no fluff and no charts — just the moving pieces investors
Goldman Sachs (GS) Stock Near Record Highs: Latest News, Forecasts and 2026 Outlook – 7 December 2025

Goldman Sachs (GS) Stock Near Record Highs: Latest News, Forecasts and 2026 Outlook – 7 December 2025

Goldman Sachs Group Inc. (NYSE: GS) is finishing the first week of December trading near all‑time highs, with investors digesting fresh deal news, institutional repositioning, and a growing disconnect between the share price and Wall Street’s average target. As of the latest close on 5 December 2025, GS shares were trading around $854–855, up roughly 2% on the day and hovering at a new 52‑week high in the mid‑$850s. Yahoo Finance+1 Below is a full rundown of the latest GS stock news, analyst forecasts and key drivers as of 7 December 2025. GS stock today: price, valuation and performance snapshot
7 December 2025
Best Green Energy Stocks to Buy Now (December 2025): 7 Top Picks for the AI Power Boom

Best Green Energy Stocks to Buy Now (December 2025): 7 Top Picks for the AI Power Boom

As of December 7, 2025, green energy stocks are back on investors’ radar. After a brutal 2021–2023 slump, the sector is benefiting from surging electricity demand from AI data centers, ongoing electrification, and a renewed focus on energy security – even as political headwinds in the U.S. make the landscape more complicated than it was a few years ago. Reuters+1 Below is a detailed, news-driven look at the best green energy stocks to watch right now, based on the latest earnings, forecasts and policy developments available on 7 December 2025. Important: This article is for information and education only, not personalized investment advice. Always do your
Best Semiconductor Stocks to Buy Now (December 7, 2025) – 10 Chip Leaders for the AI Supercycle

Best Semiconductor Stocks to Buy Now (December 7, 2025) – 10 Chip Leaders for the AI Supercycle

Updated December 7, 2025 – informational, not investment advice. The semiconductor industry is in one of the most powerful upcycles in its history. The World Semiconductor Trade Statistics (WSTS) group just raised its outlook again: it now expects global chip sales to jump about 22–23% in 2025 to roughly $772 billion, and then grow more than 26% in 2026 to around $975 billion – putting the sector within striking distance of a $1 trillion market by 2026.Semiconductor Industry Association+2SDxCentral+2 Logic and memory chips – the core of AI and data centers – are forecast to grow by more than 30% in 2026 alone.WSTS At the
Best Crypto US Stocks to Buy in December 2025: Top Miners, Exchanges and Bitcoin Treasury Plays

Best Crypto US Stocks to Buy in December 2025: Top Miners, Exchanges and Bitcoin Treasury Plays

Updated: December 7, 2025 After a euphoric run to new all‑time highs above $126,000 in October, Bitcoin has spent late 2025 in a sharp drawdown, trading closer to the mid‑$80,000–$90,000 range. ETF investors pulled a record $3.79 billion from US spot bitcoin ETFs in November as BTC fell roughly 33% from its peak, raising fresh “crypto winter 2.0” fears. 24/7 Wall St. Yet analysts from Coinbase Institutional and others argue this looks more like a mid‑cycle reset than a repeat of 2022, pointing to still‑strong institutional adoption and the prospect of Federal Reserve rate cuts on December 10. Coinbase+1 In this volatile backdrop, crypto‑linked US stocks
LAES Stock on December 7, 2025: SEALSQ’s Quantum Security Bet Faces Volatile Trading and Mixed Forecasts

LAES Stock on December 7, 2025: SEALSQ’s Quantum Security Bet Faces Volatile Trading and Mixed Forecasts

Ticker: LAES (SEALSQ Corp) • Exchange: Nasdaq • Sector: Semiconductors / Cybersecurity / Post‑Quantum Cryptography Snapshot of LAES Stock as of December 7, 2025 SEALSQ Corp (NASDAQ: LAES) goes into the weekend of December 7, 2025 trading at $4.86 per share, after falling 4.33% on Friday, December 5 from a prior close of $5.08. StockInvest According to recent market data: Despite Friday’s drop, several technical services note that LAES has risen about 34% over the last two weeks, with daily price swings regularly above 6–8%, placing the name firmly in the “very high risk” camp. StockInvest+1 On December 6, MarketBeat
PG Stock Price Near 2‑Year Low as P&G Warns on U.S. Sales: Outlook, Forecasts and Dividend Update

PG Stock Price Near 2‑Year Low as P&G Warns on U.S. Sales: Outlook, Forecasts and Dividend Update

Updated: December 7, 2025 Procter & Gamble (NYSE: PG) is trading near its lowest levels in roughly two years despite beating recent earnings expectations and maintaining one of the longest dividend‑growth streaks in the market. The stock has slid as investors digest warnings about “significantly” weaker U.S. sales, a 7,000‑job restructuring plan, and an upcoming CEO transition in early 2026. Reuters+3Investopedia+3MarketBeat+3 Below is a deep dive into the current PG stock price, the latest news as of December 7, 2025, and how analysts and models are forecasting the next moves for this consumer‑staples giant. PG stock price today and recent
7 December 2025
Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis Inc. (NASDAQ: ACB; TSX: ACB) is ending 2025 in a very different place from where it started. After years of restructuring, the company has become a highly focused global medical cannabis business, with new partnerships in Australia, expanding operations in Europe, and back‑to‑back quarters of record medical revenue. As of the latest trading sessions before December 7, 2025, ACB’s U.S.-listed shares trade around US$4.60, while the TSX listing changes hands near C$6.39, giving the company a market value in roughly the US$260–280 million range. Investing.com+2Stock Titan+2 Here’s a deep dive into the latest news, earnings, forecasts and analyses
DG Stock Today: Dollar General Surges After Q3 2025 Earnings Beat as Analysts Lift Targets

DG Stock Today: Dollar General Surges After Q3 2025 Earnings Beat as Analysts Lift Targets

As of 7 December 2025, Dollar General (NYSE: DG) has re‑entered the market spotlight. The discount retailer’s stock has ripped higher following a strong third‑quarter 2025 earnings beat, raised guidance, and a wave of analyst upgrades, even as regulators scrutinize its pricing practices and consumers show mounting financial strain.Reuters+2Investopedia+2 DG stock closed around $132 per share on 5 December 2025, near a one‑year high and up sharply from its 2024 lows.StockAnalysis With the rally, investors are asking a simple question with a not‑so‑simple answer: what’s priced in now, and what comes next for DG stock? DG Stock Snapshot: Price, Valuation
7 December 2025
UK ‘Two‑Tier State Pension’ Row: What Rachel Reeves’ Autumn Budget 2025 Means for Your Taxes and Retirement

UK ‘Two‑Tier State Pension’ Row: What Rachel Reeves’ Autumn Budget 2025 Means for Your Taxes and Retirement

The UK state pension has jumped to the top of the political and financial agenda again – not because of the usual triple‑lock debate, but because of a controversial new promise that risks creating what critics call a “two‑tier state pension”. Following the Autumn Budget 2025, Chancellor Rachel Reeves has confirmed that pensioners whose only income is the state pension will not pay income tax on it during this Parliament. Everyone else – including people with even a modest private pension or small top‑ups – will still be taxed in the usual way. Pensions Age+1 At the same time, the
7 December 2025
Tesco is Giving Away Free ‘Perfectly Imperfect’ Christmas Trees in 2025 – How the Wonky Tree Giveaway Works (and the Other Festive Freebies You Should Know About)

Tesco is Giving Away Free ‘Perfectly Imperfect’ Christmas Trees in 2025 – How the Wonky Tree Giveaway Works (and the Other Festive Freebies You Should Know About)

Shoppers across the UK have been racing to Tesco this first weekend of December after the supermarket giant confirmed it would give away hundreds of free real Christmas trees as part of its 2025 festive campaign. The catch? They’re deliberately “wonky” – slightly lopsided or gap‑toothed firs that might once have been written off as waste, now rebranded as “Perfectly Imperfect” and celebrated as symbols of a more realistic Christmas. Hortweek+4The Independent+4Goole Times+4 The one‑day giveaway, held on Saturday 6 December 2025, has quickly become one of the season’s most talked‑about money‑saving and sustainability stories, with coverage spanning national newspapers,
7 December 2025

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop